Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ)
002793.SZ Stock Price Chart
Explore Luoxin Pharmaceuticals Group Stock Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002793.SZ price movements and trends.
002793.SZ Company Profile
Discover essential business fundamentals and corporate details for Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
15 Apr 2016
Employees
3.39K
Website
https://www.luoxin.cnCEO
Zhenteng Liu
Description
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers medical treatment and health services. The company was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Luoxin Pharmaceuticals Group Stock Co., Ltd. is based in Linyi, China.
002793.SZ Financial Timeline
Browse a chronological timeline of Luoxin Pharmaceuticals Group Stock Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 21 Apr 2025
EPS came in at -¥0.85 , while revenue for the quarter reached ¥766.45M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.01 , while revenue for the quarter reached ¥482.73M .
Earnings released on 29 Oct 2024
EPS came in at -¥0.17 , while revenue for the quarter reached ¥621.68M .
Earnings released on 29 Aug 2024
EPS came in at -¥0.05 , while revenue for the quarter reached ¥570.51M .
Earnings released on 17 May 2024
EPS came in at -¥0.03 , while revenue for the quarter reached ¥683.70M .
Earnings released on 26 Apr 2024
EPS came in at -¥0.40 , while revenue for the quarter reached ¥530.27M .
Earnings released on 27 Oct 2023
EPS came in at -¥0.09 , while revenue for the quarter reached ¥571.05M .
Earnings released on 29 Aug 2023
EPS came in at -¥0.03 , while revenue for the quarter reached ¥593.03M .
Earnings released on 27 Apr 2023
EPS came in at -¥0.56 , while revenue for the quarter reached -¥182.07M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.10 , while revenue for the quarter reached ¥662.43M .
Earnings released on 30 Sept 2022
EPS came in at -¥0.28 , while revenue for the quarter reached ¥626.81M .
Earnings released on 30 Jun 2022
EPS came in at -¥0.14 , while revenue for the quarter reached ¥965.73M .
Dividend declared on 13 May 2022
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 13 May 2022.
Earnings released on 29 Apr 2022
EPS came in at ¥0.06 , while revenue for the quarter reached ¥2.18B .
Earnings released on 4 Mar 2022
EPS came in at -¥0.02 , while revenue for the quarter reached ¥1.39B .
Earnings released on 28 Oct 2021
EPS came in at ¥0.10 , while revenue for the quarter reached ¥1.65B .
Earnings released on 29 Aug 2021
EPS came in at ¥0.10 , while revenue for the quarter reached ¥1.70B .
Dividend declared on 8 Jul 2021
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 8 Jul 2021.
Earnings released on 29 Apr 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥1.74B .
Earnings released on 31 Mar 2021
EPS came in at ¥0.10 , while revenue for the quarter reached ¥1.74B .
Earnings released on 29 Oct 2020
EPS came in at ¥0.09 , while revenue for the quarter reached ¥1.68B .
002793.SZ Stock Performance
Access detailed 002793.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.